Riley Bove, MD


Dr. Riley Bove is a neurologist who provides comprehensive care for patients with multiple sclerosis, including women who are pregnant or going through menopause.

Bove's research is dedicated to finding new ways to promote neurological recovery in people with MS, including through emerging technologies and hormonal modulation. She has written over 25 articles on the role that hormones, such as estrogens and testosterone, play in regulating the course of MS and other neurological disorders. She has also written and lectured on the importance of comprehensively targeting the health needs of men with MS.

Bove also studies how technologies such as telemedicine can improve the ability of people with MS to obtain medical care, regain function and participate in research.

Bove received her medical degree from Harvard Medical School. She then completed a residency in the joint neurology program of Massachusetts General and Brigham and Women's hospitals, followed by a clinical research fellowship at the Partners Multiple Sclerosis Center. Bove also earned a master's degree through Harvard Medical School's clinical investigation program.

After graduating from Harvard with a bachelor's degree in anthropology, Bove took several years to travel the world on a Fulbright grant, learning from patients and families through ethnographic study and film work.

Bove is a member of the American Academy of Neurology and the Consortium of Multiple Sclerosis Centers. She is an assistant professor of neurology at UCSF. She speaks French, Spanish and some Portuguese.


Multiple Sclerosis Center
1500 Owens St., Suite 320
San Francisco, CA 94158
Phone: (415) 353-2069
Fax: (415) 353-2633

Hours: Monday to Friday
8 a.m. – 5 p.m.

Academic Title

Assistant Professor

More about Riley Bove

Additional Languages



Harvard School of Medicine 2007


Massachusetts General Hospital and Brigham and Women's Hospital, Neurology 2011


Partners Multiple Sclerosis Center, Brigham and Women's Hospital , Clinical Research 2015

Selected Research and Publications

  1. Damotte V, Lizée A, Tremblay M, Agrawal A, Khankhanian P, Santaniello A, Gomez R, Lincoln R, Tang W, Chen T, Lee N, Villoslada P, Hollenbach JA, Bevan CD, Graves J, Bove R, Goodin DS, Green AJ, Baranzini SE, Cree BA, Henry RG, Hauser SL, Gelfand JM, Gourraud PA. Harnessing electronic medical records to advance research on multiple sclerosis. Mult Scler. 2018 Jan 01; 1352458517747407.
  2. Bove R, Healy BC, Musallam A, Soltany P, Diaz-Cruz C, Sattarnezhad N, Glanz BI, Kivisäkk P, Miller KK, Chitnis T. Fatty acid binding protein-4 is associated with disability in multiple sclerosis patients. Mult Scler. 2018 Jan 01; 1352458517750768.
  3. Bove R, Gilmore W. Hormones and MS: Risk factors, biomarkers, and therapeutic targets. Mult Scler. 2018 Jan; 24(1):17-21.
  4. Bove RM, Hauser SL. Diagnosing multiple sclerosis: art and science. Lancet Neurol. 2017 Dec 21.
  5. Klawiter EC, Bove R, Elsone L, Alvarez E, Borisow N, Cortez M, Mateen F, Mealy MA, Sorum J, Mutch K, Tobyne SM, Ruprecht K, Buckle G, Levy M, Wingerchuk D, Paul F, Cross AH, Jacobs A, Chitnis T, Weinshenker B. High risk of postpartum relapses in neuromyelitis optica spectrum disorder. Neurology. 2017 Nov 28; 89(22):2238-2244.
  6. Bove RM, Green AJ. Remyelinating Pharmacotherapies in Multiple Sclerosis. Neurotherapeutics. 2017 Sep 25.
  7. Bove R, Chitnis T, Cree BA, Tintoré M, Naegelin Y, Uitdehaag BM, Kappos L, Khoury SJ, Montalban X, Hauser SL, Weiner HL. SUMMIT (Serially Unified Multicenter Multiple Sclerosis Investigation): creating a repository of deeply phenotyped contemporary multiple sclerosis cohorts. Mult Scler. 2017 Aug 01; 1352458517726657.
  8. Bove R, Elsone L, Alvarez E, Borisow N, Cortez MM, Mateen FJ, Mealy MA, Mutch K, Tobyne S, Ruprecht K, Buckle G, Levy M, Wingerchuk DM, Paul F, Cross AH, Weinshenker B, Jacob A, Klawiter EC, Chitnis T. Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter study. Neurol Neuroimmunol Neuroinflamm. 2017 May; 4(3):e339.
  9. Bove R, Rankin K, Chua AS, Saraceno T, Sattarnezhad N, Greeke E, Stuart F, LaRussa A, Glanz BI, Chitnis T. Oral contraceptives and MS disease activity in a contemporary real-world cohort. Mult Scler. 2017 Feb 01; 1352458517692420.
  10. Block VJ, Lizée A, Crabtree-Hartman E, Bevan CJ, Graves JS, Bove R, Green AJ, Nourbakhsh B, Tremblay M, Gourraud PA, Ng MY, Pletcher MJ, Olgin JE, Marcus GM, Allen DD, Cree BA, Gelfand JM. Continuous daily assessment of multiple sclerosis disability using remote step count monitoring. J Neurol. 2017 Feb; 264(2):316-326.
  11. Davoudi V, Keyhanian K, Bove RM, Chitnis T. Immunology of neuromyelitis optica during pregnancy. Neurol Neuroimmunol Neuroinflamm. 2016 Dec; 3(6):e288.
  12. Bove R. Patient Management Problem. Continuum (Minneap Minn). 2016 Oct; 22(5, Neuroimaging):1731-1737.
  13. Bove R. Patient Management Problem-Preferred Responses. Continuum (Minneap Minn). 2016 Oct; 22(5, Neuroimaging):1738-1746.
  14. Bove R, White CC, Fitzgerald KC, Chitnis T, Chibnik L, Ascherio A, Munger KL. Hormone therapy use and physical quality of life in postmenopausal women with multiple sclerosis. Neurology. 2016 Oct 04; 87(14):1457-1463.
  15. Bove R, Chua AS, Xia Z, Chibnik L, De Jager PL, Chitnis T. Complex relation of HLA-DRB1*1501, age at menarche, and age at multiple sclerosis onset. Neurol Genet. 2016 Aug; 2(4):e88.
  16. Bove R, Vaughan T, Chitnis T, Wicks P, De Jager PL. Women's experiences of menopause in an online MS cohort: A case series. Mult Scler Relat Disord. 2016 Sep; 9:56-9.
  17. Bove R, Musallam A, Xia Z, Baruch N, Messina S, Healy BC, Chitnis T. Longitudinal BMI trajectories in multiple sclerosis: Sex differences in association with disease severity. Mult Scler Relat Disord. 2016 Jul; 8:136-40.
  18. Bove R. Women's Issues in Multiple Sclerosis. Semin Neurol. 2016 Apr; 36(2):154-62.
  19. Bove RM, Gerweck AV, Mancuso SM, Bredella MA, Sherman JC, Miller KK. Association between adiposity and cognitive function in young men: Hormonal mechanisms. Obesity (Silver Spring). 2016 Apr; 24(4):954-61.
  20. Bove RM, White CC, Gerweck AV, Mancuso SM, Bredella MA, Sherman JC, Miller KK. Effect of growth hormone on cognitive function in young women with abdominal obesity. Clin Endocrinol (Oxf). 2016 Apr; 84(4):635-7.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.